Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 31 July

Jessica Amir
July 31, 2020

Morning Bell 30 July

Jessica Amir
July 30, 2020

Morning Bell 29 July

Jessica Amir
July 29, 2020

How to use ETFs in your portfolio

Bell Direct
July 28, 2020

Morning Bell 28 July

Jessica Amir
July 28, 2020

Morning Bell 27 July

Jessica Amir
July 27, 2020

Weekly Wrap 24 July

Jessica Amir
July 24, 2020

Morning Bell 24 July

Paulina Peters
July 24, 2020

Morning Bell 23 July

Jessica Amir
July 23, 2020

Morning Bell 22 July

Jessica Amir
July 22, 2020